PMID- 29113646 OWN - NLM STAT- MEDLINE DCOM- 20230926 LR - 20230926 IS - 1532-2661 (Electronic) IS - 0034-5288 (Linking) VI - 125 DP - 2019 Aug TI - Effects of recombinant canine interferon-gamma injected before general anesthesia with propofol and isoflurane on natural killer cytotoxic activity during anesthesia in dogs. PG - 416-420 LID - S0034-5288(17)30100-5 [pii] LID - 10.1016/j.rvsc.2017.10.003 [doi] AB - We aimed to determine whether subcutaneous injection of recombinant canine interferon-gamma (rCaIFN-gamma) 1h before general anesthesia with a combination of propofol and isoflurane (P-I) changes the cytotoxic activity of natural killer (NK) cells during anesthesia in dogs. Nine clinically healthy beagles were assigned to one of two groups: rCaIFN-gamma-treated group (n=5) and control group (no treatment, n=4). One hour before P-I anesthesia, rCaIFN-gamma was subcutaneously injected at a dose of 1x10(4)U/kg body weight for the test group and physiologic saline was subcutaneously injected for the control group. Blood samples were collected 1h before P-I anesthesia (immediately before rCaIFN-gamma injection) and 1 and 3h after anesthesia induction. NK cytotoxic activity was measured using the Rose Bengal assay, using canine thyroid adenocarcinoma cells as target cells. In the control group, NK cytotoxic activity decreased significantly over time (P<0.05). On the other hand, in the rCaIFN-gamma group, the activity increased for the first hour after anesthesia induction without a significant difference from the level before anesthesia; furthermore, the activity at 3h after anesthesia induction was comparable with that before anesthesia. NK cytotoxic activity at 1 and 3h after anesthesia induction was significantly higher in the rCaIFNgamma group than in the control group (P<0.05). Subcutaneous injection of rCaIFN-gamma 1h before P-I general anesthesia not only maintained but also enhanced NK cytotoxic activity up to 3h after anesthesia induction in dogs. In conclusion, subcutaneous injection of rCaIFN-gamma before cancer resection in cancer-bearing dogs might be effective for preventing intraoperative dissemination of cancer cells and postoperative cancer recurrence and metastasis. CI - Copyright (c) 2017 Elsevier Ltd. All rights reserved. FAU - Matsumoto, Hirotaka AU - Matsumoto H AD - Division of Therapeutic Sciences I, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180-8602, Japan. Electronic address: matsumoto@nvlu.ac.jp. FAU - Miyata, Takuma AU - Miyata T AD - Department of Animal Science, Teikyo University of Science, 2-2-1 Senjusakuragi, Adachi-ku, Tokyo 120-0045, Japan. FAU - Ohkusa, Tomoko AU - Ohkusa T AD - Division of Therapeutic Sciences I, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180-8602, Japan. FAU - Teshima, Takahiro AU - Teshima T AD - Division of Therapeutic Sciences I, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180-8602, Japan. FAU - Koyama, Hidekazu AU - Koyama H AD - Division of Therapeutic Sciences I, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180-8602, Japan. LA - eng PT - Clinical Trial, Veterinary PT - Journal Article DEP - 20171026 PL - England TA - Res Vet Sci JT - Research in veterinary science JID - 0401300 RN - 0 (Anesthetics, Inhalation) RN - 0 (Hypnotics and Sedatives) RN - 82115-62-6 (Interferon-gamma) RN - CYS9AKD70P (Isoflurane) RN - YI7VU623SF (Propofol) RN - 0 (Recombinant Proteins) SB - IM MH - Animals MH - Dogs MH - Anesthesia, General/veterinary MH - Anesthetics, Inhalation/administration & dosage/pharmacology MH - Hypnotics and Sedatives/administration & dosage/pharmacology MH - *Interferon-gamma/administration & dosage/pharmacology MH - *Isoflurane/administration & dosage/pharmacology MH - Killer Cells, Natural/drug effects/physiology MH - Postoperative Period MH - *Propofol/administration & dosage/pharmacology MH - Recombinant Proteins/pharmacology OTO - NOTNLM OT - Cytotoxic activity OT - Dog OT - IFN-gamma OT - Isoflurane OT - NK OT - Propofol EDAT- 2017/11/09 06:00 MHDA- 2019/12/04 06:00 CRDT- 2017/11/09 06:00 PHST- 2017/01/26 00:00 [received] PHST- 2017/10/17 00:00 [revised] PHST- 2017/10/25 00:00 [accepted] PHST- 2017/11/09 06:00 [pubmed] PHST- 2019/12/04 06:00 [medline] PHST- 2017/11/09 06:00 [entrez] AID - S0034-5288(17)30100-5 [pii] AID - 10.1016/j.rvsc.2017.10.003 [doi] PST - ppublish SO - Res Vet Sci. 2019 Aug;125:416-420. doi: 10.1016/j.rvsc.2017.10.003. Epub 2017 Oct 26.